Peter E. Devlin

Partner

Nova Iorque + 1.212.326.3978

Conectar

Compartilhe

For nearly two decades, Peter Devlin has advised clients in connection with transformative financing transactions and day-to-day disclosure and corporate governance matters.

Peter's broad experience ranges from global, Fortune 500 manufacturing companies to emerging life sciences companies, providing him with deep knowledge and perspective across the full spectrum of public and private securities offerings and with respect to critically important disclosure and governance issues.

In addition to U.S. companies, Peter has significant experience advising international clients on U.S. securities laws, corporate governance matters, Securities and Exchange Commission (SEC) reporting requirements, and stock exchange rules and regulations, including guiding several foreign private issuers through the legal and practical aspects of the public offering process in the United States.

Peter has worked with issuers across many different industries, including agricultural technology, biotechnology, financial technology, financial services, insurance, transportation, shipping, consumer products, manufacturing, telecommunications, and education.

His transactional experience includes a range of venture capital and growth equity financings, complex capital markets transactions, including initial public offerings (IPOs), follow-on equity offerings (primary and secondary), private placements and private investment in public equity (PIPEs), and a range of debt transactions (investment grade, high yield, and convertible). Peter also advises on U.S. securities aspects of merger and acquisition transactions, reverse mergers, and go-private transactions.

Peter is an advisory board member of the School of Science at Manhattan University.

Experiência

  • Siebert expands access to tokenized securities through new collaboration with Streamex and tZEROJones Day represented Siebert Financial Corp. (NASDAQ: SIEB), a diversified financial services company, through its wholly-owned subsidiary Muriel Siebert & Co. LLC, in connection with the private placement of GLDY, the gold-backed, yield-bearing tokenized security issued by Streamex Ltd., a subsidiary of Streamex Corp. (NASDAQ: STEX), under Rule 506(c) of Regulation D.
  • Median Technologies completes €50 million capital increaseJones Day advised Median Technologies SA, a Euronext Growth Paris-listed developer of AI-powered software as a medical device for cancer diagnosis and provider of AI-based oncology imaging services, on its upsized €50 million capital increase, including a French public offering, international private placement to qualified investors, and reserved offering to certain backup investors.
  • Nanobiotix completes $100 million follow-on offering of ADSs, Ordinary Shares, and Pre-Funded WarrantsJones Day represented Nanobiotix S.A., a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer and other major diseases, in a global follow-on offering of American Depositary Shares, Ordinary Shares, and Pre-Funded Warrants for an aggregate gross proceeds of approximately $100 million.
  • Banking syndicate completes €400 million offering of bonds convertible into new shares and/or exchangeable for existing shares (OCEANEs) by RexelJones Day advised the banking syndicate in connection with an offering of €400 million aggregate principal amount of 1.00% Senior Unsecured Bonds due 2031 convertible into new shares and/or exchangeable for existing shares (OCEANEs), by way of an offering to qualified investors only, by Rexel (Euronext Paris: RXL), a worldwide expert in the multichannel professional distribution of products and services for the energy world.
  • Georgia-Pacific completes $2 billion Senior Notes offeringJones Day represented Georgia-Pacific LLC (“Georgia-Pacific”) in connection with a Rule 144A and Regulation S offering of $700 million aggregate principal amount of 4.400% Senior Notes due 2029, $700 million aggregate principal amount of 4.600% Senior Notes due 2031, and $600 million aggregate principal amount of 4.900% Senior Notes due 2033.
  • Gorgé S.A. completes sale of Exail Technologies shares in €75.6 million institutional private placementJones Day advised Gorgé S.A., the Gorgé family's holding company and reference shareholder of Exail Technologies S.A., in connection with the successful sale of approximately 3.5% of the share capital of Exail Technologies, via an institutional private placement by way of an accelerated book-building process reserved to institutional investors at a price of €126 per share for a total amount of approximately €75.6 million.
  • Verily spins out from Alphabet and raises $300 millionJones Day represented Verily Health in its spin-out from Alphabet, Inc., corporate restructuring and $300 million new money financing.
  • Cibus completes $15 million public offering of Class A Common StockJones Day represented Cibus, Inc. (NASDAQ: CBUS) in connection with its public offering of 6,976,744 shares of Cibus' Class A Common Stock for an aggregate purchase price of approximately $15 million.
  • Financial institutions complete benchmark €6 billion 4.35% OLO by Kingdom of BelgiumJones Day assisted the financial institutions in connection with the issuance of a 30-year benchmark €6 billion 4.35% OLO (the “OLO 107”) by the Kingdom of Belgium.
  • Cibus completes $21.5 million public offering of Class A Common StockJones Day represented Cibus, Inc. (NASDAQ: CBUS) in connection with its public offering of 14,836,664 shares of Cibus' Class A Common Stock for an aggregate purchase price of approximately $21.5 million.
  • Financial institutions complete benchmark €8 billion 3.40% OLO by Kingdom of BelgiumJones Day assisted the financial institutions in connection with the issuance of a 10-year benchmark €8 billion 3.40% OLO (the “OLO 106”) by the Kingdom of Belgium.
  • OmniVision Integrated Circuits Group, Inc. completes $616 million IPO on The Stock Exchange of Hong Kong LimitedJones Day acted as Hong Kong and U.S. counsel for OmniVision Integrated Circuits Group, Inc. (“OmniVision”) in connection with its approximately US$616 million initial public offering on The Stock Exchange of Hong Kong Limited (excluding the exercise of the green shoe).
  • Sanofi successfully completes US$3 billion Notes offeringJones Day advised Sanofi, the global biopharma group, on its successful offering of US$3 billion public offering of Notes across five tranches.
  • Koch Equity Development acquires iconectiv, LLCJones Day advised Koch Equity Development LLC, the principal investment and acquisition arm of Koch, Inc., on its acquisition of iconectiv, LLC ("iconectiv"), a telecommunications solutions leader, from Ericsson (NASDAQ: ERIC), the global supplier of mobile communication and connectivity solutions for service providers and enterprises, and affiliates of Francisco Partners, a leading technology investment firm.
  • Cibus completes $27.5 million public offering of Class A Common StockJones Day represented Cibus, Inc. (NASDAQ: CBUS) in connection with its public offering of 15,714,285 shares of Cibus' Class A Common Stock for an aggregate purchase price of approximately $27.5 million.
  • Georgia-Pacific completes $1 billion Senior Notes offeringJones Day represented Georgia-Pacific LLC (“Georgia-Pacific”) in connection with its Rule 144A and Regulation S offering of $500 million aggregate principal amount of 4.400% Senior Notes due 2028 and $500 million aggregate principal amount of 4.950% Senior Notes due 2032.
  • Wabtec completes $1.25 billion public offering of Senior NotesJones Day represented Westinghouse Air Brake Technologies Corporation (“Wabtec”), a global provider of value-added, technology-based locomotives, equipment, systems and services for the freight rail and passenger transit industries, as well as the mining, marine, and industrial markets, in connection with its underwritten public offering of $500 million of 4.900% Senior Notes due 2030 and $750 million of 5.500% Senior Notes due 2035.
  • Molex completes $1 billion Senior Notes offeringJones Day represented Molex Electronic Technologies, LLC in connection with a Rule 144A and Regulation S offering of $600 million aggregate principal amount of 4.750% Senior Notes due 2028 and $400 million aggregate principal amount of 5.250% Senior Notes due 2032.
  • Cibus completes $22.6 million registered direct offering of Common Stock, Pre-Funded Warrants, and accompanying Common WarrantsJones Day represented Cibus, Inc. in connection with its registered direct offering of 4,340,000 shares of its Class A Common Stock accompanying Common Warrants to purchase an aggregate of 4,340,000 shares of its Class A Common Stock and Pre-Funded Warrants to purchase 4,700,000 shares of Class A Common Stock and accompanying Common Warrants to purchase up to an aggregate of 4,700,000 shares of its Class A Common Stock for an aggregate purchase price of approximately $22.6 million.
  • Cibus completes $12 million public offering of Class A Common StockJones Day represented Cibus, Inc. (NASDAQ: CBUS) in connection with an underwritten public offering of 3,000,000 shares of Cibus' Series A Common Stock for an aggregate purchase price of $12 million.
    •

    May 2026 Commentary

    SEC Proposes Optional Semiannual Reporting

    May 2026 Newsletters

    International Capital Markets Update | Spring 2026

    March 2026 Commentary

    A Long-Awaited Step: SEC and CFTC Provide Interpretation for Crypto Asset Taxonomy

    March 2026 Commentary

    SEC Grants Section 16(a) Exemption for Directors and Officers of Foreign Private Issuers Organized in Certain Jurisdictions

    DECEMBER 2025 Commentary

    Amendments to Exchange Act Section 16(a) Extending Insider Reporting to Foreign Private Issuers Enacted

    September 2025 Alert

    SEC Says It's a "New Day": A New Agenda and New Leadership

    Abril de 2025 Alert

    Desenvolvimentos na regulação de criptoativos: revogação das regras de reporte fiscal aplicáveis a DeFi e orientação da SEC sobre divulgação de informações

    April 2025 Alert

    Developments in Crypto Regulation: DeFi Tax Reporting Repeal and SEC Disclosure Guidance

    FEBRUARY 2025 Commentary

    Delaware Supreme Court Reverses Chancery Court and Applies Business Judgment Review to Reincorporation

    January 23 - December 10, 2024 Firm Hosted

    2024 Public Company Speaker Series
    Ver tudo

    • March 17, 2022
      What could happen next for U.S.-listed Chinese stocks?

    January 23 - December 10, 2024 Firm Hosted

    2024 Public Company Speaker Series

    • June 11, 2025
      Private Company Strategic Alternatives Symposium
    • February 5, 2025
      Bringing European Innovators to the U.S. Capital Markets
    • October 9, 2024
      Global Tends in Biotech IPOs (BioVerse Episode 14)
    • May 10, 2018
      Blockchain for Lawyers, The New York City Bar Association
    • October 15, 2018
      Virtual Token Issuance and Management, panelist, IBM IT Services Legal Summit

    Antes de enviar, por favor observe que:

    a Informação contida neste website (www.jonesday.com) destina-se a uso geral e não pode ser considerada como assessoria jurídica. O envio deste e-mail não tem por finalidade criar e seu recebimento não constitui uma relação cliente-advogado. Quaisquer conteúdos enviados para profissionais do Jones Day não são considerados confidenciais ou privilegiados a menos que sejamos seu representante legal. Ao enviar esta mensagem, você confirma que leu e concorda com este aviso.